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Abstract
Since the amounts of arachidonic acid (AA) and EPA in food may have implications for human health, we
investigated whether a small change in chicken feed influenced the blood lipid concentration in humans ingesting
the chicken. Forty-six young healthy volunteers (age 20–29) were randomly allocated into two groups in a
double-blind dietary intervention trial, involving ingestion of about 160 g chicken meat per day for 4 weeks. The
ingested meat was either from chickens given a feed concentrate resembling the commercial chicken feed,
containing 4% soybean oil (SO), or the meat was from chickens given a feed where the soybean oil had been
replaced by 2% rapeseed oil plus 2% linseed oil (RLO).
Serum total cholesterol, LDL and HDL cholesterol, triacylglycerols, serum phospholipid fatty acid concentration,
blood pressure, body weight and C-reactive protein were determined at baseline and post-intervention. In subjects
consuming chicken meat from the RLO group there was a significantly (p < 0.001) increased concentration of EPA
in serum phospholipids, and a reduced ratio between AA and EPA. The participants that had a low% of EPA + DHA
in serum phospholipids (less than 4.6%), all increased their% of EPA + DHA after the four week intervention period
when consuming the RLO chicken. No significant response differences in cholesterol, triacylglycerol, C-reactive
protein, body weight or blood pressure were observed between the groups. This trial demonstrates that a simple
change in chicken feed can have beneficial effects on amount of EPA and the AA/EPA ratio in human serum
phospholipids.
Keywords: n-3 fatty acids, Serum phospholipids, EPA, Arachidonic acid, Chicken meat, Feed, Linseed oil, Rapeseed
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Background
Chicken meat is popular to eat, and it is regarded as a
healthy type of meat [1]. In Norway poultry meat accounts
for about 25% of the total meat intake [2,3], and the con-
sumption of this type of meat has shown an increasing trend.
Meat is one of the food items that are good carriers of long
chain polyunsaturated fatty acids (LC PUFAs). The fatty acid
composition of chicken meat is affected by the type of fat in
the chicken feed. Commercial chicken feed is based on
grains and soybean oil rich in n-6 fatty acids and the ratio of
n-6 to n-3 in the feed is about 10–15/1. The potential of
chickens to convert the n-6 and n-3 feed fatty acids to the
respective long chain n-6 and n-3 fatty acids has been stud-
ied intensively, showing that the concentration of n-6 linoleic
acid, (LA) and n-3 alpha-linolenic acid, (ALA) fatty acids in
the feed influence the production of the long n-6 and n-3
fatty acids, such as arachidonic acid (AA), eicosapentaenoic
acid (EPA), docosapentaenoic acid (DPA) and docosahexae-
noic acid (DHA) in the chicken [4,5].
The n-6 and n-3 fatty acids compete for binding to
enzymes, receptors and membranes affecting cell me-
tabolism. Overproduction or imbalance (e.g. between
thromboxanes and prostacyclins) of the different eicosa-
noids are implicated in the pathogenesis, symptom se-
verity or rate of progression of several common chronic
diseases, such as allergy, cardiac diseases, cancer, pain,
rheumatoid arthritis, other inflammation and high
blood pressure [6-12]. DHA has, moreover, an
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important structural role as a major component in
membrane lipids in the brain, retina, testicles and
spermatozoa. The reasons for this are not well under-
stood, but it has been suggested that it is mainly for
improving membrane fluidity in the mitochondria, thus
facilitating electron transport through the respiratory
chain and reducing the ratio between rates of mito-
chondrial production of reactive oxygen species (ROS)
and ATP [7]. Even though much of the underlying bio-
chemical mechanisms explaining the causal connection
between dietary intakes of LC PUFAs, the dietary n-6/
n-3 ratio and eicosanoid biosynthesis and disease pro-
cesses have been known for more than 40 years, neither
the agricultural sector nor preventive medicine seem to
have shown much interest in making practical use of
the information.
From known physiology, a combination of AA over-
consumption and underconsumption of EPA and DHA
should lead to enhancement of the death risk both from
cardiovascular disease and cancer. Most of the red meat
produced in the United States has a high n-6/n-3 ratio,
e.g. pork leg (no 10010[13]) has about 25:1, beef (no
23652[13]) has 18:1, and chicken meat (no 05011[13])
has 8:1. However, grass fed beef (no 13000[13]) is shown
to have an n-6/n-3 ratio of only 2:1. The same low ratio
is shown in sheep meat from e.g. Iceland, where grass
feeding is commonly practiced, being about 1.8:1[14].
The association between red meat consumption and
death risk from cardiovascular disease or cancer in
populations who consume large quantities of red meat
with a natural fatty acid composition, has not yet been
well enough systematically evaluated.
When comparing the intakes of n-6 and n-3 fatty acids
in the western diet with the intake in earlier times, it
seems to be a higher concentration of n-6 and lower n-3
fatty acid concentration in meat, offal and eggs today
(because the n-6/n-3 ratio of the animal diet is now un-
naturally high) [6]. The high n-6 content in feeds leads
to increased synthesis of AA in the animals, and an
increased load of AA for the consumer. A change in the
n-6 and n-3 balance in the animal feed back to more
natural concentrations is healthier for the animals, and
it is safe. It is also without side effects (which all com-
monly used pharmacological inhibitors of eicosanoid
synthesis do have) and cheaper for the consumers than
to take drugs for dampening eicosanoid synthesis. It is
technologically easy and relatively inexpensive to pro-
duce poultry meat with much more long-chain n-3 fatty
acids and less arachidonic acid than now [15]. The
health economic benefits of such livestock products for
society as a whole may easily outweigh the direct costs
for the poultry farming sector. It may be concluded that
time is overdue for a better balanced intake of n-6 and
n-3 fatty acids in food.
Practical ways to improve the fatty acid composition
of chicken meat to contain less n-6 and more n-3 may
be by excluding soybean oil from the commercial feed,
and add rapeseed- and linseed oil instead. The n-6/n-3
ratio in the feed will thereby be reduced considerably,
and the ratio in the chicken meat will improve. It has
been shown that the ratio between the n-6 fatty acid AA
and the n-3 fatty acid EPA in chicken breast muscle was
about 3:1 when adding 4% rapeseed oil and 1% linseed
oil to the feed [16].
The objective of the present study was to examine the
effects of consuming a daily portion of chicken meat for
four weeks; either meat from chickens fed a traditional
feed supplemented with soybean oil, or feed with
linseed- plus rapeseed oil, on the fatty acid composition
and the ratio n-6/n-3 and AA/EPA in serum phospholi-
pids, blood lipids, C-reactive protein and blood pressure
in healthy 20–29 year old subjects.
Methods
Study design for human experiment
Forty-six healthy volunteers, 11 males and 35 females,
aged 20 to 29 years were participating in the study. The
study lasted for 28 days and was carried out in October-
November 2011. Most of the participants were students
at the Norwegian University for Life Science. The major-
ity had normal BMI; individual BMI ranged from 17.5 to
33.5. They were not taking any medications, supple-
ments or fish oil, and not eating fatty fish. The study
was double blind and randomized. The participants were
randomly allocated into one of two groups: to consume
chicken meat from chickens that had been fed a concen-
trate feed supplemented with soybean oil or with rape-
seed plus linseed oil. Some of the participants were
living together in student flats, and they were allocated
into the same group so they could cook together and eat
the same type of chicken. The participants were
recruited by two Masters students. The Masters students
were not participating in the study themselves, and did
not know the type of chicken feed. The participants were
asked to continue with their normal dietary habits, and
not to be slimming during the experimental period.
Every week, two frozen chickens (the weight of a chicken
was about 1 kg) were given to each participant. The par-
ticipants were given recipes indicating how to cook the
chickens. They told later in the study that they were not
aware of how easy it was to cook the whole chickens.
Approval of the study
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects were approved by the
Regional Committee for Medical Research Ethics and
approved by the Norwegian Data Inspectorate. Written
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informed consent was obtained from all the subjects,
and they were informed that they could quit the study
whenever they wanted without giving any reason.
Blood samples, anthropometric and blood pressure
measurements
At baseline (day 1) and at post-intervention (day 28) the
participants were weighed using the same scale (Soehnle
Digital personal scale, 467017201, Germany) and blood
pressure was measured using an automatic blood pres-
sure monitor approved for medical purposes (UA-767
Plus 30. Blood pressure monitor, A&D, Japan). The
blood pressure was taken three times according to the
instruction manual. The height was measured at baseline
using a wall mounted stadiometer, for calculation of
BMI; weight, kg / (height, m)2.
Blood samples were collected from fasting subjects
(minimum 12 h fast) at baseline and post-intervention
(between 07.00 and 10.30). The blood samples were left
for 0.5 – 2 h at room temperature before centrifuging at
1300 g for 12 minutes. Serum was then frozen and kept
at -20°C until analyzed. Blood sampling and measuring
of weight, height and blood pressure were done at the
local medical health center.
Serum analyses
Human serum phospholipid fatty acids were determined
using the following method; serum was thawed overnight
at 4°C and vortexed for 5 sec. Dichloromethane/methanol
were added to 200μl serum and 100μl internal standard
(1,2 diheptadecaonyl-sn-glycero-3-phosphatidylcholine).
After shaking and centrifugation the supernatants were
transferred to new vials and washed in 0.9% NaCl solution.
Lower phases were transferred to SPE columns. Neutral
lipids were washed out with dichloromethane /isopropa-
nol and MTBE/formic acid. Phospholipids were eluted
with methanol. After evaporation to dryness in a vacuum
centrifuge, phospholipids were transmethylated with so-
dium metoxide and FAMEs were extracted to hexane be-
fore GC analysis. Analysis was performed on a 7890A GC
with a split/split less injector, a 7683B automatic liquid
sampler, and flame ionization detection (Agilent Tech-
nologies, Palo Alto, CA). Separation was performed on a
SP 2380 (30 m×0.22 mm i.d. × 0.25 μm film thickness)
column (Supelco, Inc., Bellefonte, PA).
Determination of serum total cholesterol, HDL choles-
terol (HDL), LDL cholesterol (LDL), triacylglycerol (TAG)
and CRP was performed using routine laboratory methods
(SP 03-05 Avida 2400. Fürst Medical Laboratory, Norway).
The chicken feeding experiment; feed production and
chickens
The animals were cared for according to laws and regu-
lations controlling experiments with live animals in
Norway (The Animal Protection Act of December 20th,
1974 and the Animal Protection Ordinance Concerning
Experiments with Animals of January 15th, 1996).
The two types of chicken feed were produced at the
Center for Feed Technology, Ås, Norway. The feed was
based on wheat, and the two feed types; SO and RLO,
were identical with the exception of supplemented oil,
being either 4% soybean oil or 2% rapeseed oil (Askim
bær- og fruktpresseri, Askim, Norway) plus 2% linseed
oil (Naturata AG, Murr, Germany) (Table 1). The wheat
was ground on a hammer mill, 3 mm sieve and the feed
was pelleted with cold pelletation 3 mm, 600 kg/hour.
The feed was packed in 500 kg sacks, and it was pro-
duced the same week as the onset of the feeding of the
chickens. A small part of the feeds was ground, and this
meal was given to the small chickens the first week.
After the first week, the chickens were eating feed
pellets.
Six hundred newly hatched male broiler chickens
(Ross 308, Nortura Samvirkekylling, Norway) were ran-
domly divided into two rooms for chicken production.
The floor was covered with wood shavings, and the
Table 1 Chicken feed composition,% of ingredients
SO RLO
Wheat 45 45
Maize gluten 10 10
Soybean meal 17 17
Oat 15 15
Rendered fat 4 4
Soybean oil 4 0
Rape seed oil 0 2
Linseed oil 0 2
Choline cholride 0.13 0.13
Mono calcium phosphate 1.4 1.4
Ground limestone 1.3 1.3
Sodium chloride 0.25 0.25
Sodium bicarbonate 0.2 0.2
Mikromin Fjørfe FK50 0.15 0.15
Mikromin Selen 300FK 0.1 0.1
Vitamin A 0.03 0.03
Vitamin E 0.06 0.06
Vitamin ADBK 0.09 0.09




The two diets were identical except the content of 4% soybean oil (SO) or 2%
rapeseed oil plus 2% linseed oil (RLO).
Composition of Mikromin Fjørfe FK 50 is: 35 g Fe/kg, 10 g Cu/kg, 85 g Mn/kg,
55 g Zn/kg and 0.7 I /kg. Mikromin Selen 300 FK is: 0.3 g Se/kg. Both mixtures
are from Normin AS, Hønefoss, Norway.
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chickens had free access to water and feed. The
temperature in the two rooms was kept at 32°C for the
first three days, before being reduced by 0.5°C per day
until 21°C and then kept at this temperature until
slaughter at day 32. During the initial 24 h the chickens
were kept in continuous lighting, followed by six days
with 23 h light and one h darkness. From day seven the
lights were turned off for two periods per day; from
1700 to 2100 h, and 0000 to 0400 h. The chickens were
inspected by a veterinarian each week. In total 13 birds
died during the experiment; eight in the SO dietary
treatment group, and five in the RLO dietary treatment
group. This gives a total mortality rate of about 2%,
which is acceptable. The dead chickens did not undergo
post mortem autopsy.
At day 32, the chickens were sent to a commercial ab-
attoir; Nortura kyllingslakteri, Rakkestad, Norway, and
were slaughtered according to routine practice. The car-
casses were frozen at -20°C. Three days later the human
dietary intervention study started.
Chicken feed and chicken breast muscle analyses
The fatty acid composition of chicken feed (six parallel
samples from each feed) and chicken breast muscle (16
randomly chosen chickens from each group) was deter-
mined by extraction, methylation and gas chromatog-
raphy according to O’Fallon et al. [17]. The fatty acid
methyl esters (FAME) were separated on a fused sili-
cium dioxide capillary column (200 m× 0.25 mm id).
The carrier gas was H2, and the temperature program
went from 70°C to 230°C. The detector temperature was
290°C, and the run time for each sample was 90 min-
utes. Fatty acids were identified with reference standard
fatty acids (Sigma Aldrich, UK), and they were quantified
by use of internal standard C13:0 (Sigma Aldrich, UK),
that was added in the fatty acid extraction procedure.
Statistical analyses
The fatty acid composition and fat content of feed and
chicken muscle fatty acid were calculated using Excel.
Mean value ± standard errors of the mean are presented.
Independent Student’s t-test was used to compare base-
line values of the two groups of human participants, and
paired Student’s t-test to assess significance of the treat-
ment effect in each group, for changes in serum choles-
terol, triacylglycerols, HDL cholesterol, LDL cholesterol,
C-reactive protein and fatty acid composition of serum
phospholipids. Control for variation in baseline value
was performed using ANCOVA. Bonferroni correction
was used for multiple comparisons. We used the Statis-
tical Analysis System, SAS 9.1, and results are presented
as means ± SEM (or standard deviation when presenting
the baseline characteristics). Differences were considered
significant at p < 0.05.
Results
Participants
All of the 46 participants that were recruited for the study
successfully completed the study. They consumed about
160 g chicken meat (raw weight) per day for four weeks,
and they all gave a blood sample, measured blood pressure
and weight at the beginning and at the end of the study.
Basal characteristics
The number of men and women, age, mean and stand-
ard deviation of height, body weight, BMI, SBP, DBP,
serum cholesterol, LDL cholesterol, HDL cholesterol,
triacylglycerol and C-reactive protein of the participants
in the SO group and RLO group at baseline is shown in
Table 2. There were no significant differences among the
two groups in basal characteristics, except the number
of men being lower in the SO group compared to the
RLO group. Out of the 46 participants in the study,
there were only 11 men. Due to the situation that some
of the participants were living together in flats, and the
principle of having the same type of chicken in each
household to ease the cooking, there were only three
men in the group eating the soybean oil supplemented
chicken, and eight men in the group having the rapeseed
and linseed oil fed chicken.
Chicken intake
The weight of the chickens was on average 1.09 kg. The
participants individually made a diary describing their
Table 2 Basal characteristic of the study participants in
SO and RLO groups (n = 23 in each group)
Characteristics SO RLO P*
Mean SD Mean SD
Sex
Female (n) 20 - 15 - -
Male (n) 3 - 8 - -
Age (range) years 24 (19-29) - 24 (19-29) - -
Height (m) 1.72 0.08 1.72 0.09 0.872
Weight (kg) 68.4 10.3 70.9 12.1 0.453
BMI (kg/m2) 23.1 2.7 23.9 3.7 0.419
SBP (mmHg) 117 13 120 13 0.399
DBP (mmHg) 74 11 73 10 0.503
Cholesterol (mmol/l) 4.7 1.0 4.9 0,6 0.529
LDL (mmol/l) 3.0 0.8 3.1 0.7 0.407
HDL (mmol/l) 1.7 0.3 1.7 0.4 0.966
TAG (mmol/l) 1.1 0.4 1.1 0.4 0.739
CRP (mg/l) 2.0 3.0 2.1 3.3 0.944
Body mass index (BMI), Systolic blood pressure (SBP), diastolig blood pressure
(DBP), LDL cholesterol (LDL), HDL cholesterol (HDL) and C-reactive protein
(CRP).
SBP = Systolic blood pressure.
DBP = Diastolic blood pressure.
*Significance in mean values between groups at baseline in one-way ANOVA.
Haug et al. Lipids in Health and Disease 2012, 11:104 Page 4 of 11
http://www.lipidworld.com/content/11/1/104
intake of chicken meat. In average both groups were eating
7.5 chickens during the four weeks of intervention, and they
were having chicken most of the weekdays. A rough esti-
mate made by us showed that under the given circum-
stances with simple kitchen facilities about 55% of the
weight of raw chicken was consumed. Thus, the partici-
pants were consuming about 160 g chicken meat consisting
in average of about 95 g breast muscle and 65 g thigh
muscle per day. This corresponds to a moderate portion of
chicken meat, a portion is estimated to be 175 g (raw meat)
[18]. It has previously been shown that exchanging SO with
RLO did not affect the taste and sensory aspects of the
chicken meat (results not yet published).
Fatty acid content in the chicken feed and meat
The composition of the feed given to the two chicken
groups is show in Table 1, and the fatty acid compos-
ition of the feed is shown in Table 3. The feed compos-
ition was identical in the two diets with exception of the
source of oils added to the diets; 4% soybean oil (SO) or
2% rapeseed oil plus 2% linseed oil (RLO). The fat con-
tent of the feed was 10.3%.
The mean fatty acid content (mg fatty acid/100 g)
chicken breast muscle of 16 chickens in each group is
shown in Table 4. The mean fat content was 1.5 g fat/
100 g breast muscle in both groups. The content of the
fatty acids LA, ALA, AA, EPA, DPA and DHA was sig-
nificantly different in the two groups of chicken breast
fillets. The content of the other fatty acids in chicken
breast meat was not different between the two groups.
The sum of n-3 PUFA (ALA + EPA + DPA + DHA) and
the sum of LC n-3 PUFA (EPA + DPA + DHA) was
much higher in the meat from the chickens fed rapeseed
plus linseed oil compared to the soybean oil group.
The content of some minor and identified fatty acids;
17:0, 18:1 t6-11, 18:1c11, 20:0, 22:0, 18:3 n-6, 20:1 n-9, 20:2
n-6 and 20:3 n-6 are not shown in the Tables 3, 4, 5 and 6.
When calculating ratios between the fatty acids in the
chicken breast muscle, both AA/EPA and n-6/n-3 were
significantly lower; about 8 times and 4 times lower, re-
spectively, in the RLO meat compared to SO (Table 4).
Fatty acid composition of human serum phospholipids
As shown in Table 5, there was no significant difference
at baseline in mean percentage values of fatty acids (%
FAME) in the serum phospholipids from persons in the
SO and RLO group. In contrast to this, after interven-
tion, ALA and EPA, as well as 14:0 and 15:0 were signifi-
cantly higher in subjects eating the RLO chicken as
compared with those eating the SO fed chicken. Add-
itionally, the RLO group tended to have higher levels of
DPA (p = 0.065). The post-intervention AA/EPA and
DPA/EPA ratio was also significantly lower in the RLO
group. Otherwise there were no significant differences
between the two groups.
Absolute values of serum phospholipid fatty acids
(-mg/100 ml serum) are shown in Table 6. The total
amount of fatty acids is the same at baseline and post-
intervention; about 110 mg phospholipid fatty acids/100
ml serum. There were no differences in fatty acid con-
centrations among the two groups at baseline. After
intervention, the concentration of ALA, EPA and 15:0
was higher in serum from subjects eating RLO chicken
as compared to subjects eating the SO chicken.
Initial and post intervention values of body weight, blood
pressure and serum variables
Mean body weight, BMI, SBP, DBP, serum cholesterol,
LDL cholesterol, HDL cholesterol, triacylglycerol and C-
reactive protein (CRP) of the participants at baseline and
at the end of the intervention period (day 28) are shown
in Table 7. There were no significant group differences
in initial and post intervention values of body weight,
BMI SBP, DBP, serum cholesterol, LDL cholesterol, HDL
cholesterol, triacylglycerol and CRP, at the start of the
study compared to end of the intervention period.
The body weight of participants increased in average
about 0.3 kg during the intervention period, but this
change was not statistically significant.
Table 3 Fatty acid composition of chicken feed,% fatty








C18:2,n-6 (LA) 35.9 21.6
C18:3,n-3 (ALA) 3.61 12.33
C20:4,n-6 (AA) 0.06 0.09
C20:5,n-3 (EPA) nd nd
C22:5,n-3 (DPA) 0.04 0.04




n-3 PUFA 3.67 12.39
n6/n3 9.82 1.75
16:1 n-7/16:0 0.06 0.08
18:1 c9/18:0 3.49 4.03
The diets contained 4% soybean oil (SO) or 2% rapeseed oil plus 2% linseed
oil (RLO). (Means from six analyses of each feed).
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Serum cholesterol varied from 3.0 mmol/l (in one of the
males), to 7.6 mmol/l (in one of the females). The CRP
was below 10 mg/l in all except three readings, and two of
the values were just above 10. One participant had CRP of
173 mg/l. This reading was removed from the data. All
the other analyzed values of these persons were not
extremes, and we chose not to remove any other values.
The participants with values outside the given reference
for their age group were informed about the findings and
advised to see their personal physician for a check.
Discussion
The present study shows that a daily intake of a moder-
ate portion of chicken meat for 4 weeks can appreciably
increase the concentration of EPA in serum phospholi-
pids of young healthy humans, provided that the chick-
ens had been fed rapeseed and linseed oil instead of
similar amounts of soybean oil.
The daily intake of chicken meat, about 160 g/day, is
much higher than the average daily intake of chicken
meat in the Norwegian population; being about 50 g/day
[2,3]. The total average intake of meat per person in
Norway is estimated in two different reports to be about
130 g/day [2], and 200 g /day [3]. The subjects were
advised to follow their normal diet, but to eat as much
as possible of the two chickens they received each week,
in preference to other meats. Their average total meat
intake may therefore have been somewhat higher than
160 g/day during the study. In the present study the par-
ticipants were mostly students at The Norwegian Uni-
versity of Life Sciences, living in student accommodation
houses and having a limited budget. Since meat is ex-
pensive compared to cereal based food, they are likely to
have less meat in their regular diet than the average
Norwegian intake. Some of the students at The Norwe-
gian University of Life Sciences are taking a course in
nutrition where they undergo a dietary assessment
showing that they have a diet based on much bread and
cereals, milk and milk products, some meat, some fish,
margarine, vegetables and fruit.
The chickens
The RLO feed resulted in a significant increase in EPA,
DPA and DHA and a decrease in AA in the chicken
breast fillets (Table 4). The chicken is thus a good pro-
ducer of LC n-3 PUFA from ALA, and chicken meat has
potential to be a good source of LC n-3 PUFA in the
human diet. The concentration of LC PUFA (AA + EPA +
DPA + DHA) made from LA and ALA was 112 mg/100 g
in the SO chicken breast muscle and 124 mg/100 g in the
RLO group. The percentages of LA + ALA in the two
feeds were 40% and 34% of the total fatty acids, respect-
ively, indicating that the synthesis of LC PUFA from LA
and ALA was higher in breast muscle from the RLO
group compared to the SO group. Thus a diet containing
rapeseed and linseed oil appears to trigger the chicken to
synthesize LC PUFA. This has also been indicated by
others in chickens [4], pigs [19] and bulls [20].
The ability of the chickens and other domestic
animals to produce EPA, DPA and DHA from ALA
should be valued and given more focus seen in light of
the limitations in the world supply of LC n-3 PUFAs
from fish and marine sources. To replace the soybean
oil (that is now the commonly used feed oil) with
linseed and rapeseed oil seems to be an efficient way
to increase the intake of LC n-3 PUFA for humans
without having to change dietary habits or to take fish
oil supplement pills.
Table 4 Fatty acid concentration, mg/100 g of chicken
breast filet from 16 animals fed a diet containing 4%
soybean oil (SO) or 16 animals fed a diet containing 2%
rapeseed oil plus 2% linseed oil (RLO)
SO RLO P*
Mean SEM Mean SEM
C14:0 9.75 1.20 9.85 1.03 0.951
C15:0 2.32 0.25 2.44 0.22 0.718
C16:0 307 28 287 25 0.585
C16:1 n-7 43.9 6.42 42.2 4.70 0.832
C18:0 142 10.31 137 10.44 0.736
C18:1,c9 451 55.45 507 53.6 0.469
C18:2,n-6 (LA) 379 42.78 245 21.0 0.009
C18:3,n-3 (ALA) 29.9 4.17 103 11.54 0.000
C20:4,n-6 (AA) 73.2 2.22 42.73 1.36 0.000
C20:5,n-3 (EPA) 4.54 0.24 21.19 0.61 0.000
C22:5,n-3 (DPA) 20.0 1.03 39.25 1.87 0.000
C22:6,n-3 (DHA) 14.1 0.97 20.41 1.10 0.000
SFA 459 39.74 433 36.0 0.634
MUFA 495 61.68 550 58.2 0.523
PUFA 521 48.04 472 34.8 0.420
n-3 PUFA 68.5 4.73 184 13.3 0.000
LC n-3 PUFA 38.6 1.72 80.9 2.97 0.000
AA/EPA 16.55 0.71 2.03 0.07 0.000
n-6/n-3 6.48 0.26 1.56 0.02 0.000
16:1n-7/16:0 0.13 0.01 0.14 0.00 0.240
18:1c9/18:0 3.03 0.18 3.65 0.13 0.010
AA/LA 0.23 0.03 0.19 0.01 0.146
EPA/ALA 0.22 0.05 0.23 0.02 0.879
DPA/EPA 4.52 0.28 1.86 0.09 0.000
DHA/DPA 0.72 0.05 0.53 0.02 0.001
(Mean values and standard errors, SEM).
*Significance in mean values between groups.
SFA: sum of 14:0, 16:0 and 18:0.
MUFA: sum of 16:1 n-7 and 18:1 n-9.
PUFA: sum of LA, ALA, AA, EPA, DPA and DHA.
n-3 PUFA: sum of ALA, EPA, DPA and DHA.
LC n-3 PUFA: sum of EPA, DPA and DHA.
n-6/n-3: (LA + AA)/(ALA + EPA + DPA + DHA).
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As seen from Table 4, the daily intake of EPA + DPA +
DHA when eating a portion of 175 g of breast muscle
from the RLO chicken would be 142 mg. This is 57% of
the proposed EFSA reference intake value of LC n-3
PUFA (250 mg/day) to reduce the risk of CVD [21].
Chicken breast meat from the SO fed group contained
68 mg in 175 g breast meat, thus a portion of the RLO
chicken breast meat contained 74 mg more LC n-3
PUFA than the traditional SO chicken. The optimal dose
for LC n-3 PUFA remains to be established. The EFSA
Panel in 2010 [22] has suggested that 450 mg may be a
recommended daily intake of LC n-3 PUFA. This shows
that even if all meat consumed had about the same fatty
acid composition as the RLO breast meat from this
experiment, it would not be enough alone to cover the
recommended intake of LC n-3 PUFA.
The chicken thigh meat may be about four to five
times higher in fat content compared to the breast meat
[4,23], but the percentage of LC n-3 PUFA (g/100 g fatty
acids) is lower in thigh meat compared to breast meat
[4]. Thus, the LC n-3 PUFA content is somewhat (about
30–50%) higher in thigh muscle compared to breast
muscle [4], and by consuming 175 g of the RLO thigh
muscle the LC n-3 PUFA intake can be estimated to be
about 190 mg instead of 142 mg when consuming the
breast muscle.
The concentration of AA was lower in the RLO chicken
breast muscle compared to SO. This is in accordance to
Table 5 Fatty acid composition of serum phospholipids at baseline and post-intervention in persons eating chickens
fed soybean oil supplement (SO) and rapeseed and linseed oil supplement (RLO), (% of total fatty acids, FAME)
Fatty acid SO group (n = 23) RLO group (n = 23) P} P}
Baseline Post-intervention Baseline Post-intervention
Mean SEM Mean SEM Mean SEM Mean SEM
C14:0 0.37 0.02 0.34 0.02 0.37 0.02 0.41 0.03 0.894 0.029
C15:0 0.23 0.01 0.21 0.01 0.25 0.01 0.25 0.01 0.127 0.004
C16:0 29.5 0.45 29.2 0.41 29.4 0.39 28.8 0.41 0.903 0.460
C16:1,n-7 0.67 0.05 0.61 0.04 0.57 0.04 0.57 0.03 0.114 0.455
C18:0 13.5 0.35 13.2 0.31 13.4 0.28 13.1 0.29 0.966 0.873
C18:1,c9 10.18 0.31 9.42 0.31 9.32 0.26 9.48 0.27 0.042 0.887
C18:2,n-6 (LA) 20.2 0.58 20.3 0.47 21.0 0.53 20.7 0.52 0.285 0.537
C18:3,n-3 (ALA) 0.27 0.02 0.23 0.01 0.26 0.02 0.36 0.03 0.735 0.000
C20:4,n-6 (AA) 8.41 0.39 10.21 0.46 9.16 0.36 9.66 0.34 0.167 0.340
C20:5,n-3 (EPA) 1.03 0.09 0.80 0.05 1.09 0.09 1.26 0.09 0.669 0.000
C22:5,n-3 (DPA) 0.91 0.05 0.92 0.05 0.92 0.05 1.08 0.06 0.836 0.065
C22:6,n-3 (DHA) 4.94 0.28 4.77 0.26 4.63 0.26 4.57 0.20 0.421 0.545
SFA 43.3 0.19 42.7 0.22 43.3 0.17 42.3 0.21 0.736 0.163
MUFA 10.8 0.32 10.0 0.32 9.89 0.29 10.0 0.29 0.034 0.967
PUFA 35.7 0.42 37.2 0.51 37.1 0.53 37.6 0.46 0.052 0.540
n-3 PUFA 7.15 0.35 6.72 0.29 6.90 0.34 7.26 0.27 0.614 0.187
LCn-3 PUFA 6.88 0.36 6.49 0.30 6.64 0.35 6.90 0.27 0.633 0.307
AA/EPA 9.25 0.74 13.84 1.07 9.73 0.89 8.72 0.88 0.679 0.001
n-6/n-3 4.23 0.23 4.73 0.22 4.62 0.25 4.33 0.19 0.251 0.166
16:1 n-7/16:0 0.02 0.00 0.02 0.00 0.02 0.00 0.02 0.00 0.100 0.542
18:1 c9/18:0 0.76 0.03 0.72 0.03 0.70 0.03 0.73 0.03 0.113 0.849
EPA/ALA 4.19 0.46 3.66 0.27 4.75 0.67 3.85 0.35 0.498 0.672
DPA/EPA 0.95 0.05 1.22 0.08 0.91 0.05 0.88 0.03 0.607 0.000
DHA/DPA 5.73 0.38 5.49 0.36 5.30 0.37 4.56 0.33 0.429 0.065
}Significance in mean values between groups at baseline.
} Significance in mean values between groups after the 4 week intervention period.
SFA: sum of 14:0, 16:0 and 18:0.
MUFA: sum of 16:1 n-7 and 18:1 n-9.
PUFA: sum of LA, ALA, AA, EPA, DPA and DHA.
n-3 PUFA: sum of ALA, EPA, DPA and DHA.
LC n-3 PUFA: sum of EPA, DPA and DHA.
n-6/n-3: (LA + AA)/(ALA + EPA + DPA + DHA).
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findings by Poureslami et al. and is shown in both breast
muscle and in thigh muscle [4]. The reduction in AA con-
centration in meat may have implications for the con-
sumer given the nature of the competition between AA
and EPA for binding to enzymes and cellular structures
[7]. It has been found that purified COX-1 oxygenates
EPA at a rate which is only 10% of the rate for AA, while
EPA significantly inhibits AA oxygenation by COX-1 [24].
A portion of breast meat from the RLO chicken contained
75 mg AA, while the SO meat contained 128 mg, and the
ratio of AA/EPA was only 2 in the RLO chicken breast
meat compared to nearly 17 in the meat in the SO group.
Such a big difference in AA and EPA balance could be
expected to have an impact on the prostanoid synthesis
both for the chicken itself and for the consumer eating the
chicken.
The human intervention study
In the present study, an increase in EPA and ALA con-
centrations, and a decrease in the ratio AA/EPA in
serum phospholipids were shown in the persons con-
suming the RLO chickens. This is in line with the study
of Weill et al. and McAfee et al. showing that subjects
consuming meat from animals offered a concentrate feed
supplemented with linseed oil or a grass based diet had
higher LC n-3 PUFA concentrations in erythrocytes, pla-
telets and plasma compared to subjects consuming ani-
mal products from animals fed a standard diet [25,26].
Table 6 Fatty acid concentration (mg/100 ml serum) of serum phospholipids at baseline and post-intervention in
persons eating chickens fed soybean oil supplement (SO) and rapeseed and linseed oil supplement (RLO)
SO group (n = 23) RLO group (n = 23) P} P}
Baseline Post-intervention Baseline Post-intervention
Mean SEM Mean SEM Mean SEM Mean SEM
C14:0 0.42 0.03 0.39 0.03 0.43 0.04 0.46 0.03 0.889 0.158
C15:0 0.26 0.01 0.24 0.01 0.28 0.01 0.28 0.01 0.192 0.033
C16:0 33.99 1.47 33.49 1.60 33.73 1.23 31.87 1.20 0.889 0.423
C16:1,n-7 0.79 0.08 0.72 0.07 0.67 0.06 0.65 0.06 0.224 0.449
C18:0 15.34 0.58 15.00 0.62 15.30 0.50 14.53 0.56 0.958 0.576
C18:1,c9 11.64 0.50 10.82 0.63 10.75 0.55 10.56 0.54 0.238 0.757
C18:2,n-6 (LA) 22.90 0.76 23.00 0.86 23.96 0.88 22.89 0.91 0.368 0.932
C18:3,n-3 (ALA) 0.31 0.03 0.27 0.02 0.31 0.03 0.40 0.03 0.912 0.001
C20:4,n-6 (AA) 9.72 0.61 11.59 0.65 10.40 0.48 10.63 0.45 0.386 0.234
C20:5,n-3 (EPA) 1.20 0.13 0.92 0.08 1.23 0.10 1.40 0.10 0.860 0.001
C22:5,n-3 (DPA) 1.04 0.07 1.04 0.06 1.04 0.06 1.18 0.07 0.944 0.128
C22:6,n-3 (DHA) 5.74 0.44 5.44 0.38 5.26 0.31 5.04 0.26 0.382 0.395
}Significance in mean values between groups at baseline.
} Significance in mean values between groups after the 4 week intervention period.
Table 7 Weight, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, LDL cholesterol
(LDL), HDL cholesterol (HDL), triacylglycerol (TAG) and C-Reactive Protein (CRP) of study participants at baseline and
post-intervention in SO and RLO treatment groups (n = 23 participants in each group)
SO group (n = 23) RLO group (n = 23) P} P}
Baseline Post-intervention Baseline Post-intervention
Mean SEM Mean SEM Mean SEM Mean SEM
Weight (kg) 68.39 2.15 68.57 2.15 70.90 2.53 71.31 2.52 0.453 0.414
BMI (kg/m2) 23.11 0.57 23.17 0.57 23.89 0.77 24.02 0.77 0.419 0.376
SBP (mmHg) 116.7 2.30 115.5 1.93 119.9 2.42 117.9 2.15 0.399 0.366
DBP (mmHg) 73.63 1.60 70.7 1.40 73.2 1.84 71.3 1.84 0.503 0.903
Cholesterol (mmol/l) 4.72 0.20 4.59 0.18 4.87 0.13 4.68 0.13 0.529 0.681
LDL (mmol/l) 2.95 0.17 2.88 0.16 3.13 0.15 3.05 0.12 0.407 0.408
HDL (mmol/l) 1.65 0.06 1.61 0.07 1.66 0.08 1.60 0.08 0.966 0.902
TAG (mmol/l) 1.10 0.08 1.10 0.13 1.06 0.09 1.06 0.10 0.739 0.810
CRP (mg/l) 1.99 0.62 2.53 0.68 2.06 0.69 2.38 0.64 0.944 0.872
}Significance in mean values between groups at baseline.
} Significance in mean values between groups after the 4 week intervention period.
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The fatty acid composition of serum phospholipids has
become established as a valid marker for assessing the
status of various fatty acids and to predict dietary fat
intakes [27]. As reviewed by Fekete et al. [28], four
weeks intervention time and sampling of serum
phospholipid fatty acids was a suitable method for study-
ing long-term LC n-3 status in humans.
The content of EPA in 160 g breast muscle from the
RLO chicken was 34 mg. In contrast, the content of EPA
in the SO chicken breast muscle was only 7 mg per day.
Since the participants were not eating oily fish during
the study, most of their dietary EPA intake originated
from the chicken meat. EPA is synthesized in the body
from ALA, but there are variations in the ability to con-
vert ALA to EPA [29-31], and it may be speculated that
to some persons a dietary intake of EPA is imperative.
The concentration of EPA in serum phospholipids was
1.4 mg/100 ml serum (about 1.3% of FAME) in the RLO
treatment group and 0.9 mg/100 ml (about 0.8% of
FAME) in the SO group. The EPA concentrations varied
between the persons, and at post intervention time three
persons in the SO diet group had levels lower than 0.5
mg EPA in phospholipids/100 ml serum (0.5% FAME),
but in the RLO group no persons had lower levels than
0.5 mg EPA in phospholipids/100 ml serum post trial.
The sum of EPA plus DHA in serum phospholipids
have in populations studies been linked to assess risk of
heart disease [32,33]. EPA + DHA levels amounting to
more than 4.6% of total fatty acids in serum phospholi-
pids have been associated with a 70% lower risk com-
pared to those with a lower level of these fatty acids
[32,33]. In the present study, at baseline, three test sub-
jects in the SO group had less than 4.6% of EPA + DHA
(percent of total fatty acids) in serum phospholipids, and
five subjects in the RLO were below 4.6%. After the
intervention period, two of the three persons in the SO
group had reduced their EPA + DHA sum, while all five
of the persons in the RLO group improved (increased)
their sum of percent EPA + DHA in serum phospholi-
pids. Thus, in the present study, nearly 1/5 of the sub-
jects had less than 4.6% of EPA + DHA in their serum
phospholipids. Consumption of the RLO chicken gave
an increase in EPA + DHA in serum phospholipids of
persons already low in EPA + DHA, and this might the-
oretically contribute to reduce the risk of coronary heart
disease [32,33].
The DPA concentration in serum phospholipids was at
about the same level as EPA, but the DHA concentration
in serum phospholipids was about five times higher in
both treatment groups. In the chicken meat however, it is
different; DPA was the most abundant of these three fatty
acids, and especially in the RLO chicken there was much
DPA (39 mg/100 g meat, Table 4). DPA can be converted
to both EPA and DHA [34]. The DPA percentage in serum
phospholipids of the subjects eating the RLO chicken
showed a tendency to be higher compared to those eating
the SO chicken, and to have a significantly lower DPA/
EPA ratio (Table 5). No increase in the serum phospho-
lipid concentration of DHA in the test subjects eating
RLO chicken meat was observed, although EPA was
enhanced. The reasons for this are unknown. One possible
explanation might be faster removal of DHA than of EPA
from the blood plasma of our test subjects.
The concentration of ALA in serum phospholipids
was about 30% higher in the RLO group than the SO
group. This is plausible since the amount of ALA in the
RLO breast muscle was higher (three times higher) than
the SO breast meat.
The ratio AA/EPA was significantly lower in serum
phospholipids from the persons eating the RLO chicken.
This ratio has been shown to affect the production of
different types of eicosanoids and prostanoids [35], and
the production of eicosanoids and prostanoids may be
altered in a favorable direction towards lower production
of thromboxanes of the 2-series which should imply
reduced risk of thrombosis.
There were no differences in the concentration of AA
in serum phospholipids between the subjects consuming
RLO and SO chickens. In the SO group, the AA concen-
tration was higher at post-intervention compared to
baseline being 10.2% and 8.4%, (Table 5). It may be
speculated that high intake of AA rich meat during the
intervention period may increase AA levels in serum
phospholipids. However, Kawabata et al. showed no cor-
relations between dietary AA intake and AA in blood
lipid fractions [36].
The difference in numbers of men and women in the
two intervention groups was of concern, since women
have been reported to have a more efficient synthesis of
EPA, DPA and DHA from ALA [37]. When calculating
the results for men and women separately, there was,
however, no difference between the sexes in this study,
and the final results would not be different if we
excluded the men from the study.
There were no significant differences in serum pre or
post trial concentrations of total cholesterol, LDL chol-
esterol, HDL cholesterol or triacylglycerol in the two
intervention groups. This is in accordance to the study
of McAfee et al. [26], where the participants were con-
suming red meat with different amounts of LC PUFAs.
Even if the intake of LC n-3 PUFA is nearly twice as
high in the RLO group compared to the SO group, the
intakes may be too low to significantly affect serum
cholesterol or triacylglycerol [38,39].
In the present study with young subjects having normal
blood pressure there were no effects on blood pressure
when eating the two different meats. Long chain n-3
PUFAs have been shown to have mild antihypertensive
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effect [11,40], however, the difference in LC n-3 PUFA
intake between the two groups may have been too low
to reveal any effects. There were no differences in CRP
between the two groups. Although research studies
have suggested that LC n-3 PUFA may have anti-
inflammatory effects [12,39], this was not observed in
the present study with young healthy persons.
Conclusion
Ingestion of chicken meat from chickens fed a diet con-
taining rapeseed plus linseed oil increased EPA and
reduced the AA/EPA ratio in serum phospholipids in
young healthy persons compared to persons eating
chicken meat from birds raised on a diet containing soy-
bean oil (similar to a commercially available chicken).
All the five persons who had less than 4.6% of EPA +
DHA in their serum phospholipids at baseline, improved
(increased) the sum of EPA + DHA after the four week
intervention when consuming chickens fed rapeseed
plus linseed oil supplementation.
The chicken produces some LC n-3 PUFA from ALA,
and chicken meat may become a good dietary source of
LC n-3 PUFA provided that the birds are given rapeseed
and linseed oil instead of soybean oil. This can be an
efficient and easy way to increase the amount of LC n-3
PUFA in the general human diet, without having to
make any changes in food habits.
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